Gestin Tablet contains Allylestrenol 5mg, a synthetic progestogen primarily indicated for the management of threatened miscarriage, habitual abortion, and other conditions associated with progesterone deficiency during pregnancy. Allylestrenol exerts its therapeutic effect by mimicking the natural hormone progesterone, thereby supporting the maintenance of the endometrial lining and preventing uterine contractions that may lead to pregnancy loss. It is commonly prescribed to women with a history of recurrent pregnancy loss or those exhibiting symptoms suggestive of threatened abortion, such as vaginal bleeding or cramping. The tablet is administered orally, with dosage and duration tailored according to the clinical condition and physician’s discretion. Gestin Tablet is generally well-tolerated; however, potential side effects may include mild gastrointestinal disturbances, headache, or dizziness. Caution is advised in patients with a history of thromboembolic disorders, hepatic impairment, or hormone-sensitive malignancies. It is contraindicated in cases of known hypersensitivity to Allylestrenol or other progestogens, unexplained vaginal bleeding, and certain hormone-dependent cancers. Regular monitoring and follow-up are recommended to assess therapeutic response and detect any adverse effects. Gestin Tablet should be used under strict medical supervision to ensure optimal maternal and fetal outcomes.